Amgen, one of the world’s leading biotechnology companies, will invest $550 million to build a new manufacturing facility in Holly Springs, NC. The investment will bring 355 jobs to Holly Springs, which has become a preferred destination for the life sciences industry.
“Amgen has a long history in biologics manufacturing and continues to innovate and develop new technologies to better serve patients. At this new facility, we plan to include some of our most advanced technologies,” said Arleen Paulino, Amgen Senior Vice President of Manufacturing. “We chose North Carolina for this new plant because of the robust biologics ecosystem, and we are excited to partner with the Wake County business community to further expand biotechnology regionally.”
